1. Aljaibeji, Hayat, Mohammed, Abdul Khader, Alkayyali, Sami, Taneera, Jalal, Sulaiman, Nabil. 2020. Genetic Variants of the PLCXD3 Gene Are Associated with Risk of Metabolic Syndrome in the Emirati Population. In Genes, 11, . doi:10.3390/genes11060665. https://pubmed.ncbi.nlm.nih.gov/32570874/
2. Bishop, Matthew T, Sanchez-Juan, Pascual, Knight, Richard S G. 2013. Splice site SNPs of phospholipase PLCXD3 are significantly associated with variant and sporadic Creutzfeldt-Jakob disease. In BMC medical genetics, 14, 91. doi:10.1186/1471-2350-14-91. https://pubmed.ncbi.nlm.nih.gov/24028506/
3. Chen, Kaidi, Chen, Xiuqiong, Wang, Xinyue, Pan, Yi, Jiang, Richeng. 2025. PLCXD3-ALK, a novel ALK rearrangement in lung squamous cell carcinoma and its clinical responses to ALK inhibitors. In Journal of thoracic disease, 17, 93-108. doi:10.21037/jtd-24-1428. https://pubmed.ncbi.nlm.nih.gov/39975736/
4. Jamain, Stéphane, Cichon, Sven, Etain, Bruno, Bellivier, Frank, Leboyer, Marion. 2014. Common and rare variant analysis in early-onset bipolar disorder vulnerability. In PloS one, 9, e104326. doi:10.1371/journal.pone.0104326. https://pubmed.ncbi.nlm.nih.gov/25111785/
5. Li, Zhiming, Zheng, Zaozao, Ruan, Jun, Zhuang, Xuan, Tzeng, Chi-Meng. . Integrated analysis miRNA and mRNA profiling in patients with severe oligozoospermia reveals miR-34c-3p downregulates PLCXD3 expression. In Oncotarget, 7, 52781-52796. doi:10.18632/oncotarget.10947. https://pubmed.ncbi.nlm.nih.gov/27486773/
6. Mo, Shuangyang, Wang, Yingwei, Yuan, Xin, Jiang, Haixing, Qin, Shanyu. 2023. Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and atherosclerosis. In Frontiers in cardiovascular medicine, 10, 1142296. doi:10.3389/fcvm.2023.1142296. https://pubmed.ncbi.nlm.nih.gov/37063958/